This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
Wilde MI and McTavish D. Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia / Drugs 1996; 52: 883 898.
Wolzt M, Fabrizii V, Dorner GT, Zanaschka G, Leufkens P, Krauwinkel WJ, and Eichler HG. Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open label single dose and multiple dose study / Eur J Clin Pharmacol 1998; 54: 367 373.
Dunn CJ, Matheson A, and Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms / Drugs Aging 2002; 19: 135 161.
Andersson KE. Alpha adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha adrenoceptor antagonists/ World J Urol 2002; 19: 390 96.
Miyazawa Y, Forrest A, Schentag JJ, Kamimura H, Swarz H, and Ito Y. Effect of concomitant administration of cimetidine hydrochloride on the pharmacokinetic and safety profile of Tamsulosin hydrochloride 0.4 mg in healthy subjects / Current Therapeutic Research 2002; 63: 15 26.
Maruenda J, Bhatnagar V, and Lowenthal DT. Hypertension in the elderly with coexisting benign prostatic hyperplasia / Urology. 1999; 53: 7 12.
Lowe FC. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect / Clin Ther 1997; 19: 730 742.
Мiyazawa Y, Blum RA, Schentag JJ, Kamimura H, Matsushima H, Swarz H, and Ito Y. Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function/ Current Therapeutic Research 2001; 62: 603 621.